{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:40:56Z","timestamp":1773114056945,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.atherosclerosis.2014.12.043","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T23:50:52Z","timestamp":1419378652000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3573-4760","authenticated-orcid":false,"given":"Giuseppe","family":"Derosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4285-6507","authenticated-orcid":false,"given":"Pamela","family":"Maffioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.12.043_bib1","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/archinte.164.13.1427","article-title":"Effectiveness of statin therapy in adults with coronary heart disease","volume":"164","author":"Wilt","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"3 Suppl.\u00a0l","key":"10.1016\/j.atherosclerosis.2014.12.043_bib2","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jacl.2014.03.002","article-title":"An assessment by the statin intolerance panel: 2014 update","volume":"8","author":"Guyton","year":"2014","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2014.12.043_bib3","article-title":"Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practice","author":"Derosa","year":"2014","journal-title":"Expert Rev. Endocr. Metab."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.12.043_bib4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1517\/14712598.2012.704014","article-title":"Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials","volume":"12","author":"Derosa","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.043_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1517\/14712598.2013.776037","article-title":"Effects of berberine on lipid profile in subjects with low cardiovascular risk","volume":"13","author":"Derosa","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.043_bib6","first-page":"709","article-title":"Effects of berberis aristata\/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients","volume":"27","author":"Derosa","year":"2013","journal-title":"J.\u00a0Biol. Regul. Homeost. Agents"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.043_bib7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1517\/14712598.2013.832751","article-title":"Berberis aristata\/silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients","volume":"13","author":"Derosa","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.12.043_bib8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.043_bib9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","article-title":"Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats","volume":"12","author":"Chen","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.043_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0773.2002.t01-1-910403.x","article-title":"The involvement of P-glycoprotein in berberine absorption","volume":"91","author":"Pan","year":"2002","journal-title":"Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.043_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12272-008-1127-4","article-title":"Effect of ion-pair formation with bile salts on the in\u00a0vitro cellular transport of berberine","volume":"31","author":"Chae","year":"2008","journal-title":"Arch. Pharm. Res."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.043_bib12","first-page":"410","article-title":"A\u00a0review of plants used in the treatment of liver disease: part 1","volume":"3","author":"Luper","year":"1998","journal-title":"Altern. Med. Rev."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.043_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1081\/DMR-120028427","article-title":"Herbal modulation of P-glycoprotein","volume":"36","author":"Zhou","year":"2004","journal-title":"Drug Metab. Rev."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.043_bib14","first-page":"193","article-title":"A\u00a0review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos)","volume":"10","author":"Kidd","year":"2005","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.atherosclerosis.2014.12.043_bib15","series-title":"The Council for International Organisation of Medical Sciences","author":"Proposed International Guidelines for Biomedical Research Involving Human Subjects","year":"1982"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2014.12.043_bib16","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2014.12.043_bib17","series-title":"Obesity: Preventing and Managing the Global Epidemic","author":"World Health Organization","year":"1997"},{"key":"10.1016\/j.atherosclerosis.2014.12.043_bib18","first-page":"151","article-title":"1999 world health organization-international society of hypertension guidelines for the management of hypertension. guidelines subcommittee","volume":"17","year":"1999","journal-title":"J.\u00a0Hypertens."},{"issue":"25","key":"10.1016\/j.atherosclerosis.2014.12.043_bib19","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report","volume":"106","author":"NCEP","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.043_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00380-008-1109-y","article-title":"Oral fat load effects on inflammation and endothelial stress markers in healthy subjects","volume":"24","author":"Derosa","year":"2009","journal-title":"Heart Vessels"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.043_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mvr.2010.03.012","article-title":"Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects","volume":"80","author":"Derosa","year":"2010","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.atherosclerosis.2014.12.043_bib22","series-title":"Statistical Principles in Experimental Design","author":"Winer","year":"1971"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.12.043_bib23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.metabol.2008.01.037","article-title":"Combination of simvastatin with berberine improves the lipid-lowering efficacy","volume":"57","author":"Kong","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2014.12.043_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/DMSO.S33718","article-title":"Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control","volume":"5","author":"Di Pierro","year":"2012","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2014.12.043_bib25","first-page":"1045","article-title":"Effect of berberine on insulin secretion and glucokinase activity of NIT-1 cells","volume":"42","author":"Wang","year":"2007","journal-title":"Yao Xue Xue Bao"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.043_bib26","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.bbagen.2006.09.007","article-title":"Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK","volume":"1760","author":"Cheng","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.12.043_bib27","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ptr.1988","article-title":"The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial","volume":"20","author":"Huseini","year":"2006","journal-title":"Phytother. Res."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014016657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T19:51:10Z","timestamp":1566157870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014016657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0021915014016657"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.043","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}